Nivolumab (anti-PD-1; Bms-936558, Ono-4538) in combination with platinum-based doublet chemotherapy (PT-DC) or erlotinib in advanced non-small cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Antonia, S. J.; Rizvi, N. A.; Chow, L. Q.; Borghaei, H.; Brahmer, J. R.; Juergens, R.; Shepherd, F. A.; Laurie, S. A.; Gerber, D. E.; Goldman, J.; Shen, Y.; Harbison, C.; Chen, A. C.; Gettinger, S. |
| Abstract Title: | Nivolumab (anti-PD-1; Bms-936558, Ono-4538) in combination with platinum-based doublet chemotherapy (PT-DC) or erlotinib in advanced non-small cell lung cancer (NSCLC) |
| Meeting Title: | 6th Latin American Conference on Lung Cancer (LALCA) |
| Keywords: | erlotinib; chemotherapy; immunotherapy; nivolumab |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 9 |
| Issue: | 9 Suppl. 3 |
| Meeting Dates: | 2014 Aug 21-23 |
| Meeting Location: | Lima, Peru |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2014-12-01 |
| Start Page: | S153 |
| Language: | English |
| ACCESSION: | WOS:000344627100004 |
| PROVIDER: | wos |
| DOI: | 10.1097/01.JTO.0000454720.94093.d1 |
| Notes: | Meeting Abstract: O.3 -- Source: Wos |
